The role of botulinum toxin injections in the management of muscle overactivity of the lower limb

References

• Gracies J M. Pathophysiology of spastic paresis. I: Paresis and soft tissue changes. Muscle Nerve 2005; 31(5)535–551
   PubMed Web of Science ®Google Scholar
• Gracies J M. Pathophysiology of spastic paresis. II: Emergence of muscle overactivity. Muscle Nerve 2005; 31(5)552–571
   PubMed Web of Science ®Google Scholar
• Lance J W. Symposium synopsis. Spasticity: Disordered motor control, R G Feldman, R R Young, W P Koella. Year Book Medical, Chicago 1980; 485–494
   Google Scholar
• Sheean G. The pathophysiology of spasticity. Eur J Neurol 2002, Suppl. 1: 3–9
   PubMed Web of Science ®Google Scholar
• Powers R K, Campbell D L, Rymer W Z. Stretch reflex dynamics in spastic elbow flexor muscles. Ann Neurol 1989, 1: 32–42
   PubMed Web of Science ®Google Scholar
• Katz R T, Rymer W Z. Spastic hypertonia: Mechanisms and measurement. Arch Phys Med Rehabil 1989; 70(2)144–155
   PubMed Web of Science ®Google Scholar
• Thilmann A F, Fellows S J, Garms E. The mechanism of spastic muscle hypertonus. Variation in reflex gain over the time course of spasticity. Brain 1991; 114(Pt 1A)233–244
   PubMedGoogle Scholar
• Landau W M. Spasticity after stroke: Why bother?. Stroke 2004; 35(8)1787–1788
   PubMed Web of Science ®Google Scholar
• Gracies J M. Pathophysiology of impairment in patients with spasticity and use of stretch as a treatment of spastic hypertonia. Phys Med Rehabil Clin N Am 2001; 12(4)747–768
   PubMedGoogle Scholar
• Gracies J M, Elovic E, McGuire J, Simpson D. Traditional pharmacologic treatments of spasticity. Part 1. Local treatments. Spasticity: Etiology, evaluation, and the role of botulinum toxin, N H Mayer, D M Simpson. WE MOVE, New York 2002; 44–64
   Google Scholar
• Gracies J M. Physiological effects of botulinum toxin in spasticity. Mov Disord 2004, Suppl. 8: S120–128
   PubMedGoogle Scholar
• Dressler D, Benecke R. Pharmacology of therapeutic botulinum toxin preparations. Disabil Rehab 2007; 29: 1761–1768
   PubMed Web of Science ®Google Scholar
• Coffield J A, Bakry N, Zhang R D, Carlson J, Gomella L G, Simpson L L. In vitro characterization of botulinum toxin types A, C and D action on human tissues: Combined electrophysiologic, pharmacologic and molecular biologic approaches. J Pharmacol Exp Ther 1997; 280(3)1489–1498
   PubMed Web of Science ®Google Scholar
• Aoki K R, Guyer B. Botulinum toxin type A and other botulinum toxin serotypes: A comparative review of biochemical and pharmacological actions. Eur J Neurol 2001; 8(Suppl. 5)21–29
   PubMed Web of Science ®Google Scholar
• Callaway J E. Botulinum toxin type B (Myobloc): Pharmacology and biochemistry. Clin Dermatol 2004; 22(1)23–28
   PubMed Web of Science ®Google Scholar
• Dolly J O, Aoki K R. The structure and mode of action of different botulinum toxins. Eur J Neurol 2006, Suppl 4: 1–9
   PubMed Web of Science ®Google Scholar
• Turkel C C, Bowen B, Liu J, Brin M F. Pooled analysis of the safety of Botulinum Toxin type A in the treatment of poststroke spasticity. Arch Phys Med Rehabil 2006; 87: 786–792
   PubMed Web of Science ®Google Scholar
• Hughes R, Whaler B C. Influence of nerve ending activity and of drugs on the rate of paralysis of rat diaphragm preparations by Clostridium botulinum type A toxin. J Physiol 1962; 160: 221–223
   PubMed Web of Science ®Google Scholar
• Eleopra R, Tugnoli V, De Grandis D. The variability in the clinical effect induced by botulinum toxin type A: The role of muscle activity in humans. Mov Disord 1997; 12: 89–94
   PubMed Web of Science ®Google Scholar
• Chen R, Karp B I, Goldstein S R, Bara-Jimenez W, Yaseen Z, Hallett M. Effect of muscle activity immediately after botulinum toxin injection for writer's cramp. Mov Disord 1999; 14: 307–312
   PubMed Web of Science ®Google Scholar
• Hesse S, Jahnke M T, Luecke D, Mauritz K H. Short-term electrical stimulation enhances the effectiveness of Botulinum toxin in the treatment of lower limb spasticity in hemiparetic patients. Neurosci Lett 1995; 201(1)37–40
   PubMed Web of Science ®Google Scholar
• Bayram S, Sivrioglu K, Karli N, Ozcan O. Low-dose botulinum toxin with short-term electrical stimulation in post-stroke spastic drop foot: A preliminary study. Am J Phys Med Rehabil 2006; 85(1)75–81
   PubMed Web of Science ®Google Scholar
• de Kroon J R, van der Lee J H, IJzerman M J, Lankhorst G J. Therapeutic electrical stimulation to improve motor control and functional abilities of the upper extremity after stroke: A systematic review. Clin Rehabil 2002; 16(4)350–360
   PubMed Web of Science ®Google Scholar
• Bolton D A, Cauraugh J H, Hausenblas H A. Electromyogram-triggered neuromuscular stimulation and stroke motor recovery of arm/hand functions: A meta-analysis. J Neurol Sci 2004; 30;223(2)121–127
   Web of Science ®Google Scholar
• Pomeroy V M, King L M, Pollock A, Baily-Hallam A, Langhorne P. Electrostimulation for promoting recovery of movement or functional ability after Stroke. Systematic review and meta-analysis. Stroke 2006; 37: 2441–2442
   Web of Science ®Google Scholar
• Manni E, Bagolini B, Pettorossi V E, Errico P. Effect of botulinum toxin on extraocular muscle proprioception. Doc Ophtalmol 1989; 72: 189–198
   PubMed Web of Science ®Google Scholar
• Filippi G M, Errico P, Santarelli R, Bagolini B, Manni E. Botulinum A toxin effects on rat jaw muscle spindles. Acta Otolaryngol (Stockh) 1993; 113: 400–404
   PubMed Web of Science ®Google Scholar
• Rosales R L, Arimura K, Takenaga S, Osame M. Extrafusal and intrafusal muscle effects in experimental botulinum toxin-A injection. Muscle Nerve 1996; 19: 488–496
   PubMed Web of Science ®Google Scholar
• Gracies J M, Wilson L, Gandevia S C, Burke D. Stretched position of spastic muscles aggravates their co-contraction in hemiplegic patients. Ann Neurol 1997; 42: 438–439
   Google Scholar
• Proske U, Morgan D L, Gregory J E. Thixotropy in skeletal muscle and in muscle spindles: A review. Prog Neurobiol 1993; 41(6)705–721
   PubMed Web of Science ®Google Scholar
• Shaari C M, George E, Wu B L, Biller H F, Sanders I. Quantifying the spread of botulinum toxin through muscle fascia. Laryngoscope 1991; 101: 960–964
   PubMed Web of Science ®Google Scholar
• George E F, Zimbler M, Wu B L, Biller H F, Sanders I. Quantitative mapping of the effect of botulinum toxin injections in the thyroarytenoid muscle. Ann Otol Rhinol Laryngol 1992; 101: 888–892
   PubMed Web of Science ®Google Scholar
• Girlanda P, Vita G, Nicolosi C, Milone S, Messina C. Botulinum toxin therapy: Distant effects on neuromuscular transmission and autonomic nervous system. J Neurol Neurosurg Psych 1992; 55: 844–845
   PubMed Web of Science ®Google Scholar
• Solomon B A, Hayman R. Botulinum toxin type A therapy for palmar and digital hyperhidrosis. J Am Acad Dermatol 2000; 42: 1026–1029
   PubMed Web of Science ®Google Scholar
• Swartling C, Farnstrand C, Abt G, Stalberg E, Naver H. Side-effects of intradermal injections of botulinum A toxin in the treatment of palmar hyperhidrosis: A neurophysiological study. Eur J Neurol 2001; 8: 451–456
   PubMed Web of Science ®Google Scholar
• Dressler D, Benecke R. Autonomic side effects of botulinum toxin type B treatment of cervical dystonia and hyperhidrosis. Eur Neurol 2003; 49: 34–38
   PubMed Web of Science ®Google Scholar
• Pastor A M, Moreno-Lopez B, De La Cruz R R, Delgado-Garcia J M. Effects of botulinum neurotoxin type A on abducens motoneurons in the cat: Ultrastructural and synaptic alterations. Neuroscience 1997; 81: 457–478
   PubMed Web of Science ®Google Scholar
• Sanders D B, Massey E W, Buckley E G. Botulinum toxin for blepharospasm: Single fiber EMG studies. Neurology 1986; 36: 545–547
   PubMed Web of Science ®Google Scholar
• Lange D J, Brin M F, Warner C L, Fahn S, Lovelace R E. Distant effects of local injection of botulinum toxin. Muscle Nerve 1987; 10: 552–555
   PubMed Web of Science ®Google Scholar
• Lange D J, Rubin M, Greene P E, Kand U J, Moskowitz C B, Brin M F, Lovelace R E, Fahn S. Distant effects of locally injected botulinum toxin: A double-blind study of single fiber EMG changes. Muscle Nerve 1991; 41: 672–675
   Web of Science ®Google Scholar
• Olney R K, Aminoff M J, Gelb D J, Lowenstein D H. Neuromuscular effects distant from the site of botulinum neurotoxin injection. Neurology 1988; 38: 1780–1783
   PubMed Web of Science ®Google Scholar
• Wohlfarth K, Schubert M, Rothe B, Elek J, Dengler R. Remote F-wave changes after local botulinum toxin application. Clin Neurophysiol 2001; 112(4)636–640
   PubMed Web of Science ®Google Scholar
• Boroff D A, Chen G S. On the question of permeability of the blood-brain barrier to botulinum toxin. Int Arch Allergy Appl Immunol 1975; 48: 495–504
   PubMedGoogle Scholar
• Wiegand H, Erdmann G, Wellhoner H H. 125 I-labeled botulinum A neurotoxin: Pharmacokinetics in cats after neuromuscular injection. Naunyn Schmiedebergs Arch Pharmacol 1976; 292: 161–165
   PubMed Web of Science ®Google Scholar
• Dolly J O, Williams R S, Black J D, Tse C K, Hambleton P, Melling J. Localization of sites for 125I-labelled botulinum neurotoxin at murine neuromuscular junction and its binding to rat brain synaptosomes. Toxiconology 1982; 20: 141–148
   PubMed Web of Science ®Google Scholar
• Hagenah R, Benecke R, Wiegand H. Effects of type A botulinum toxin on the cholinergic transmission at spinal Renshaw cells and on the inhibitory action at Ia inhibitory interneurones. Naunyn Schmiedebergs Arch Pharmacol 1977; 299: 267–272
   PubMed Web of Science ®Google Scholar
• Mikhailov V V. Electrophysiological analysis of disturbances in reflex activity of the spinal cord in experimental botulism. Bull Exp Biol Med 1958; 46: 1188–1192
   Google Scholar
• Mikhailov V V, Barashkov G N. Mechanism of disorders of inhibition of electrogenesis in spinal alpha-motor neurons in experimental local botulin poisoning. Biull Eksp Biol Med 1977; 83: 651–654, [in Russian]
   PubMedGoogle Scholar
• Moreno-Lopez B, Pastor A M, de la Cruz R R, Delgado-Garcia J M. Dose-dependent, central effects of botulinum neurotoxin type A: A pilot study in the alert behaving cat. Neurology 1997; 48: 456–464
   PubMed Web of Science ®Google Scholar
• Wiegand H, Wellhoner H H. Proceedings: Type A botulinum toxin in cats: Neural ascent and action on spinal cord reflexes. Naunyn Schmiedebergs Arch Pharmacol 1974; 282(Suppl.)R106
   Google Scholar
• Wiegand H, Wellhöner H H. The action of botulinum A neurotoxin on the inhibition by antidromic stimulation of the lumbar monosynaptic reflex. Naunyn Schmiedebergs Arch Pharmacol 1977; 298: 235–238
   PubMed Web of Science ®Google Scholar
• Guyton A C, McDonald M A. Physiology of botulinus toxin. Arch Neurol Psych 1947; 57: 578–592
   PubMedGoogle Scholar
• Mallart A, Molgo J, Angaut-Petit D, Thesleff S. Is the internal calcium regulation altered in type A botulinum toxin-poisoned motor endings?. Brain Res 1989; 479: 167–171
   PubMed Web of Science ®Google Scholar
• Tyler H R. Physiological observations in human botulism. Arch Neurol 1963; 9: 661–670
   Web of Science ®Google Scholar
• Gracies J M, Elovic E, McGuire J, Simpson D M. Traditional pharmacological treatments for spasticity. Part I: Local treatments. Muscle Nerve Suppl. 1997; 6: S61–91
   PubMedGoogle Scholar
• Hultborn H, Jankowska E, Lindstrom S. Recurrent inhibition from motor axon collaterals of transmission in the Ia inhibitory pathway to motoneurones. J Physiol 1971; 215: 591–612
   PubMed Web of Science ®Google Scholar
• Priori A, Berardelli A, Mercuri B, Manfredi M. Physiological effects produced by botulinum toxin treatment of upper limb dystonia. Changes in reciprocal inhibition between forearm muscles. Brain 1995; 118: 801–807
   PubMed Web of Science ®Google Scholar
• Modugno N, Priori A, Berardelli A, Vacca L, Mercuri B, Manfredi M. Botulinum toxin restores presynaptic inhibition of group Ia afferents in patients with essential tremor. Muscle Nerve 1998; 21(12)1701–1705
   PubMed Web of Science ®Google Scholar
• Pauri F, Boffa L, Cassetta E, Pasqualetti P, Rossini P M. Botulinum toxin type-A treatment in spasticity increases the central conduction time to brain stimulation. Electroencephalogr Clin Neurophysiol Suppl 1999; 51: 250–259
   PubMedGoogle Scholar
• Pauri F, Boffa L, Cassetta E, Pasqualetti P, Rossini P M. Botulinum toxin type-A treatment in spastic paraparesis: A neurophysiological study. J Neurol Sci 2000; 181: 89–97
   PubMed Web of Science ®Google Scholar
• Bischoff C, Schoenle P W, Conrad B. Increased F-wave duration in patients with spasticity. Electromyogr Clin Neurophysiol 1992; 32: 449–453
   PubMedGoogle Scholar
• Hultborn H, Nielsen J B. Comments: Methodological problems of comparing F responses and H reflexes. Muscle Nerve 1996; 19: 1347–1348
   PubMed Web of Science ®Google Scholar
• Hultborn H, Nielsen J B. H-reflexes and F-responses are not equally sensitive to changes in motoneuronal excitability. Muscle Nerve 1995; 18: 1471–1474
   PubMed Web of Science ®Google Scholar
• Gelb D J, Yoshimura D M, Olney R K, Lowenstein D H, Aminoff M J. Change in pattern of muscle activity following botulinum toxin injections for torticollis. Ann Neurol 1991; 29: 370–376
   PubMed Web of Science ®Google Scholar
• Valls-Sole J, Tolosa E S, Ribera G. Neurophysiological observations on the effects of botulinum toxin treatment in patients with dystonic blepharospasm. J Neurol Neurosurg Psych 1991; 54: 310–313
   PubMed Web of Science ®Google Scholar
• Behari M, Raju G B. Electrophysiological studies in patients with blepharospasm before and after botulinum toxin A therapy. J Neurol Sci 1996; 135: 74–77
   PubMed Web of Science ®Google Scholar
• Girlanda P, Quartarone A, Sinicropi S, Nicolosi C, Messina C. Unilateral injection of botulinum toxin in blepharospasm: Single fiber electromyography and blink reflex study. Mov Disord 1996; 11: 27–31
   PubMed Web of Science ®Google Scholar
• Valls-Sole J, Tolosa E S, Marti M J, Allam N. Treatment with botulinum toxin injections does not change brainstem interneuronal excitability in patients with cervical dystonia. Clin Neuropharmacol 1994; 17: 229–235
   PubMed Web of Science ®Google Scholar
• Tardieu G, Tardieu C, Hariga J. Infiltrations with 45 degrees ethyl alcohol of the motor points, the roots by the epidural route, or of the posterior tibial nerve. Their indications and contra-indications in the various forms of spasticity (experience of 10 years). Rev Neurol (Paris) 1971; 125: 63–68
   PubMedGoogle Scholar
• Tardieu G. Troubles du maintien postural des membres supérieurs. Les Feuillets de l'Infirmité Motrice Cérébrale, Chapitre VB1f. Association Nationale des IMC Ed, Paris 1972; 1–10
   Google Scholar
• Tardieu G, Tardieu C, Hariga J. Selective partial denervation by alcohol injections and their results in spasticity. Reconstr Surg Traumatol 1972; 13: 18–36
   PubMedGoogle Scholar
• McLellan D L. Co-contraction and stretch reflexes in spasticity during treatment with baclofen. J Neurol Neurosurg Psych 1977; 40: 30–38
   PubMed Web of Science ®Google Scholar
• Knutsson E, Richards C. Different types of disturbed motor control in gait of hemiparetic patients. Brain 1979; 102: 405–430
   PubMed Web of Science ®Google Scholar
• Knutsson E, Martensson A. Dynamic motor capacity in spastic paresis and its relation to prime mover dysfunction, spastic reflexes and antagonist co-activation. Scand J Rehabil Med 1980; 12: 93–106
   PubMedGoogle Scholar
• Hammond M C, Fitts S S, Kraft G H, Nutter P B, Trotter M J, Robinson L M. Co-contraction in the hemiparetic forearm: Quantitative EMG evaluation. Arch Phys Med Rehabil 1988; 69: 348–351
   PubMed Web of Science ®Google Scholar
• Wing A M, Lough S, Turton A, Fraser C, Jenner J R. Recovery of elbow function in voluntary positioning of the hand following hemiplegia due to stroke. J Neurol Neurosurg Psych 1990; 53: 126–134
   PubMed Web of Science ®Google Scholar
• Levin M F, Hui-Chan C. Ankle spasticity is inversely correlated with antagonist voluntary contraction in hemiparetic subjects. Electromyogr Clin Neurophysiol 1994; 34: 415–425
   PubMedGoogle Scholar
• Levin M F. Interjoint coordination during pointing movements is disrupted in spastic hemiparesis. Brain 1996; 119(Pt 1)281–293
   PubMed Web of Science ®Google Scholar
• Levin M F, Selles R W, Verheul M H, Meijer O G. Deficits in the coordination of agonist and antagonist muscles in stroke patients: implications for normal motor control. Brain Res 2000; 853: 352–369
   PubMed Web of Science ®Google Scholar
• Unnithan V B, Dowling J J, Frost G, Bar-Or O. Role of cocontraction in the O2 cost of walking in children with cerebral palsy. Med Sci Sports Exerc 1996; 28: 1498–1504
   PubMed Web of Science ®Google Scholar
• Unnithan V B, Dowling J J, Frost G, Volpe Ayub B, Bar-Or O. Cocontraction and phasic activity during GAIT in children with cerebral palsy. Electromyogr Clin Neurophysiol 1996; 36: 487–494
   PubMedGoogle Scholar
• Dewald J P, Pope P S, Given J D, Buchanan T S, Rymer W Z. Abnormal muscle coactivation patterns during isometric torque generation at the elbow and shoulder in hemiparetic subjects. Brain 1995; 118(Pt 2)495–510
   PubMed Web of Science ®Google Scholar
• Levin M F, Dimov M. Spatial zones for muscle coactivation and the control of postural stability. Brain Res 1997; 757: 43–59
   PubMed Web of Science ®Google Scholar
• Hubley-Kozey C, Earl E M. Coactivation of the ankle musculature during maximal isokinetic dorsiflexion at different angular velocities. Eur J Appl Physiol 2000; 82(4)289–289
   PubMed Web of Science ®Google Scholar
• Croce R V, Miller J P. Coactivation patterns of the medial and lateral hamstrings based on joint position and movement velocity during isokinetic movements. Electromyogr Clin Neurophysiol 2006; 46(2)113–122
   PubMedGoogle Scholar
• Kamper D G, Rymer W Z. Impairment of voluntary control of finger motion following stroke: Role of inappropriate muscle coactivation. Muscle Nerve 2001; 24(5)673–681
   PubMed Web of Science ®Google Scholar
• Gracies J M, Weitz D J, Yang B Y, Flanagan S, Simpson D. Evidence for increased antagonist strength and movement speed following botulinum toxin injections in spasticity. Neurology 2001; 56: A3
   Google Scholar
• Nielsen J, Kagamihara Y. The regulation of disynaptic reciprocal Ia inhibition during co-contraction of antagonistic muscles in man. J Physiol 1992; 456: 373–391
   PubMed Web of Science ®Google Scholar
• Nielsen J, Kagamihara Y. The regulation of presynaptic inhibition during co-contraction of antagonistic muscles in man. J Physiol 1993; 464: 575–593
   PubMed Web of Science ®Google Scholar
• Nielsen J, Sinkjaer T, Toft E, Kagamihara Y. Segmental reflexes and ankle joint stiffness during co-contraction of antagonistic ankle muscles in man. Exp Brain Res 1994; 102: 350–358
   PubMed Web of Science ®Google Scholar
• Llewellyn M, Yang J F, Prochazka A. Human H-reflexes are smaller in difficult beam walking than in normal treadmill walking. Exp Brain Res 1990; 83: 22–28
   PubMed Web of Science ®Google Scholar
• Nielsen J, Nagaoka M, Kagamihara Y, Kakuda N, Tanaka R. Discharge of muscle afferents during voluntary co-contraction of antagonistic ankle muscles in man. Neurosci Lett 1994; 170: 277–280
   PubMed Web of Science ®Google Scholar
• Nielsen J, Pierrot-Deseilligny E. Evidence of facilitation of soleus-coupled Renshaw cells during voluntary co-contraction of antagonistic ankle muscles in man. J Physiol 1996; 493(Pt 2)603–611
   PubMed Web of Science ®Google Scholar
• Farmer S F, Harrison L M, Ingram D A, Stephens J A. Plasticity of central motor pathways in children with hemiplegic cerebral palsy. Neurology 1991; 41: 1505–1510
   PubMed Web of Science ®Google Scholar
• Katz R, Pierrot-Deseilligny E. Recurrent inhibition of alpha-motoneurons in patients with upper motor neuron lesions. Brain 1982; 105(Pt 1)103–124
   PubMed Web of Science ®Google Scholar
• Crone C, Nielsen J, Petersen N, Ballegaard M, Hultborn H. Disynaptic reciprocal inhibition of ankle extensors in spastic patients. Brain 1994; 117(Pt 5)1161–1168
   PubMed Web of Science ®Google Scholar
• Nakashima K, Rothwell J C, Day B L, Thompson P D, Shannon K, Marsden C D. Reciprocal inhibition between forearm muscles in patients with writer's cramp and other occupational cramps, symptomatic hemidystonia and hemiparesis due to stroke. Brain 1989; 112(Pt 3)681–697
   PubMed Web of Science ®Google Scholar
• Faist M, Mazevet D, Dietz V, Pierrot-Deseilligny E. A quantitative assessment of presynaptic inhibition of Ia afferents in spastics. Differences in hemiplegics and paraplegics. Brain 1994; 117(Pt 6)1449–1455
   PubMed Web of Science ®Google Scholar
• Nielsen J, Petersen N, Crone C. Changes in transmission across synapses of Ia afferents in spastic patients. Brain 1995; 118(Pt 4)995–1004
   PubMed Web of Science ®Google Scholar
• Morita H, Crone C, Christenhuis D, Petersen N T, Nielsen J B. Modulation of presynaptic inhibition and disynaptic reciprocal Ia inhibition during voluntary movement in spasticity. Brain 2001; 124(Pt 4)826–837
   PubMed Web of Science ®Google Scholar
• Hamjian J A, Walker F O. Serial neurophysiological studies of intramuscular botulinum-A toxin in humans. Muscle Nerve 1994; 17: 1385–1392
   PubMed Web of Science ®Google Scholar
• Hagenah R. Neuropharmacologic and neurotoxic studies on the Renshaw mechanism. Fortschr Med 1979; 97(41)1840–1844
   PubMedGoogle Scholar
• Hesse S, Brandl-Hesse B, Seidel U, Doll B, Gregoric M. Lower limb muscle activity in ambulatory children with cerebral palsy before and after the treatment with Botulinum toxin A. Restor Neurol Neurosci 2000; 17: 1–8
   PubMed Web of Science ®Google Scholar
• Heinen F, Molenaers G, Fairhurst C, Carr L J, Desloovere K, Chaleat Valayer E, Morel E, Papavassiliou A S, Tedroff K, Ignacio Pascual-Pascual S, Bernert G, Berweck S, Di Rosa G, Kolanowski E, Krageloh-Mann I. European consensus table 2006 on botulinum toxin for children with cerebral palsy. Eur J Paediatr Neurol 2006; 10(5 – 6)215–225
   PubMed Web of Science ®Google Scholar
• Gibson N, Graham H K, Love S. Botulinum toxin A in the management of focal muscle overactivity in children with cerebral palsy. Disabil Rehab 2007; 29: 1813–1822
   PubMed Web of Science ®Google Scholar
• Denny-Brown D. The cerebral control of movement. Liverpool University Press, LiverpoolUK 1966; 124–143, 171 – 184
   Google Scholar
• Tardieu G. Description classique et étude critique des cinq formes d'infirmité motrice cerébrale internationalement retenues. Classifications diverses Les Feuillets de l'Infirmité Motrice Cérébrale. Association Nationale des IMC Ed, Paris 1969; 1–8, Chapitre VB1a
   Google Scholar
• Lance J W, McLeod J G. A physiological approach to clinical neurology3rd ed. Butterworths, London 1981; 145
   Google Scholar
• Burke D. An approach to the treatment of spasticity. Drugs 1975; 10: 112–120
   PubMed Web of Science ®Google Scholar
• Burke D. Spasticity as an adaptation to pyramidal tract injury. Adv Neurol 1988; 47: 401–423
   PubMedGoogle Scholar
• Young R R. Spasticity: A review. Neurology 1994; 44(Suppl. 9)S12–20
   PubMedGoogle Scholar
• Ada L, O'Dwyer N, O'Neill E. Relation between spasticity, weakness and contracture of the elbow flexors and upper limb activity after stroke: An observational study. Disabil Rehabil 2006; 28(13 – 14)891–897
   PubMed Web of Science ®Google Scholar
• Baker J H, Hall-Craggs E C. Changes in length of sarcomeres following tenotomy of the rat soleus muscle. Anat Rec 1978; 192: 55–58
   PubMedGoogle Scholar
• Baker J H, Hall-Craggs E C. Changes in sarcomere length following tenotomy in the rat. Muscle Nerve 1980; 3: 413–416
   PubMed Web of Science ®Google Scholar
• McLachlan E M. Rapid atrophy of mouse soleus muscles after tenotomy depends on an intact innervation. Neurosci Lett 1981; 25: 269–274
   PubMed Web of Science ®Google Scholar
• McLachlan E M. Modification of the atrophic effects of tenotomy on mouse soleus muscles by various hind limb nerve lesions and different levels of voluntary motor activity. Exp Neurol 1983; 81: 669–682
   PubMed Web of Science ®Google Scholar
• McLachlan E M. Atrophic effects of proximal tendon transection with and without denervation on mouse soleus muscles. Exp Neurol 1983; 81: 651–668
   PubMed Web of Science ®Google Scholar
• McLachlan E M, Chua M. Rapid adjustment of sarcomere length in tenotomized muscles depends on an intact innervation. Neurosci Lett 1983; 35: 127–133
   PubMed Web of Science ®Google Scholar
• Booth F W, Seider M J. Early change in skeletal muscle protein synthesis after limb immobilization of rats. J Appl Physiol 1979; 47: 974–977
   PubMed Web of Science ®Google Scholar
• Booth F W. Effect of limb immobilization on skeletal muscle. J Appl Physiol 1982; 52: 1113–1118
   PubMed Web of Science ®Google Scholar
• Williams P E, Goldspink G. Connective tissue changes in immobilised muscle. J Anat 1984; 138(Pt 2)343–350
   PubMedGoogle Scholar
• Tabary J C, Tabary C, Tardieu C, Tardieu G, Goldspink G. Physiological and structural changes in cat's soleus muscle due to immobilization at different lengths by plaster casts. J Physiol (Lond) 1972; 224: 231–244
   Google Scholar
• Tardieu C, Tardieu G, Colbeau-Justin P, Huet de la Tour E, Lespargot A. Trophic muscle regulation in children with congenital cerebral lesions. J Neurol Sci 1979; 42: 357–364
   PubMedGoogle Scholar
• Ranson S W, Dixon H H. Elasticity and ductility of muscle in myostatic contracture caused by tetanus toxin. Am J Physiol 1928; 86: 312–319
   Google Scholar
• Pollock L J, Davis L. Studies in decerebration. VI. The effect of deafferentation upon decerebrate rigidity. Am J Physiol 1930; 98: 47–49
   Google Scholar
• Huet de la Tour E, Tardieu C, Tabary J C, Tabary C. Decrease of muscle extensibility and reduction of sarcomere number in soleus muscle following a local injection of tetanus toxin. J Neurol Sci 1979; 40: 123–131
   PubMed Web of Science ®Google Scholar
• Tabary J C, Tardieu C, Tardieu G, Tabary C. Experimental rapid sarcomere loss with concomitant hypoextensibility. Muscle Nerve 1981; 4(3)198–203
   PubMed Web of Science ®Google Scholar
• Cosgrove A P, Graham H K. Botulinum toxin A prevents the development of contractures in the hereditary spastic mouse. Dev Med Child Neurol 1994; 36: 379–385
   PubMed Web of Science ®Google Scholar
• Corry I S, Cosgrove A P, Walsh E G, McClean D, Graham H K. Botulinum toxin A in the hemiplegic upper limb: A double-blind trial. Dev Med Child Neurol 1997; 39(3)185–193
   PubMed Web of Science ®Google Scholar
• Corry I S, Cosgrove A P, Duffy C M, McNeill S, Taylor T C, Graham H K. Botulinum toxin A compared with stretching casts in the treatment of spastic equinus: A randomised prospective trial. J Pediatr Orthop 1998; 18: 304–311
   PubMed Web of Science ®Google Scholar
• Thompson N S, Baker R J, Cosgrove A P, Corry I S, Graham H K. Musculoskeletal modelling in determining the effect of botulinum toxin on the hamstrings of patients with crouch gait. Dev Med Child Neurol 1998; 40: 622–625
   PubMed Web of Science ®Google Scholar
• Eames N W, Baker R, Hill N, Graham K, Taylor T, Cosgrove A. The effect of botulinum toxin A on gastrocnemius length: magnitude and duration of response. Dev Med Child Neurol 1999; 41(4)226–232
   PubMed Web of Science ®Google Scholar
• Cosgrove A P, Corry I S, Graham H K. Botulinum toxin in the management of the lower limb in cerebral palsy. Dev Med Child Neurol 1994; 36: 386–396
   PubMed Web of Science ®Google Scholar
• Koman L A, Mooney J F, III, Smith B P, Walker F, Leon J M. Botulinum toxin type A neuromuscular blockade in the treatment of lower extremity spasticity in cerebral palsy: A randomized, double-blind, placebo-controlled trial. BOTOX Study Group. J Pediatr Orthop 2000; 20: 108–115
   PubMed Web of Science ®Google Scholar
• Flett P J, Stern L M, Waddy H, Connell T M, Seeger J D, Gibson S K. Botulinum toxin A versus fixed cast stretching for dynamic calf tightness in cerebral palsy. J Paediatr Child Health 1999; 35(1)71–77
   PubMed Web of Science ®Google Scholar
• Bang M S, Chung S G, Kim S B, Kim S J. Change of dynamic gastrocnemius and soleus muscle length after block of spastic calf muscle in cerebral palsy. Am J Phys Med Rehabil 2002; 81(10)760–764
   PubMed Web of Science ®Google Scholar
• Polak F, Morton R, Ward C, Wallace W A, Doderlein L, Siebel A. Double-blind comparison study of two doses of botulinum toxin A injected into calf muscles in children with hemiplegic cerebral palsy. Dev Med Child Neurol 2002; 44(8)551–555
   PubMed Web of Science ®Google Scholar
• Scott A B. Injection treatment of endocrine orbital myopathy. Doc Ophthalmol 1984; 58: 141–145
   PubMed Web of Science ®Google Scholar
• Scott A B. Change of eye muscle sarcomeres according to eye position. J Pediatr Ophthalmol Strabismus 1994; 31: 85–88
   PubMed Web of Science ®Google Scholar
• Scott A B, Kraft S P. Botulinum toxin injection in the management of lateral rectus paresis. Ophthalmology 1985; 92: 676–683
   PubMed Web of Science ®Google Scholar
• Kowal L, Wong E, Yahalom C. Botulinum toxin in the treatment of strabismus: A review of its use and effects. Disabil Rehab 2007; 29: 1823–1831
   PubMed Web of Science ®Google Scholar
• Bakheit A M. Optimising the methods of evaluation of the effectiveness of botulinum toxin treatment of post-stroke muscle spasticity. J Neurol Neurosurg Psych 2004; 75(5)665–666
   PubMed Web of Science ®Google Scholar
• Turner-Stokes L, Ashford S. Serial injection of botulinum toxin for muscle imbalance due to regional spasticity in the upper limb. Disabil Rehab 2007; 29: 1806–1812
   PubMed Web of Science ®Google Scholar
• Snow B J, Tsui J K, Bhatt M H, Varelas M, Hashimoto S A, Calne D B. Treatment of spasticity with botulinum toxin: A double-blind study. Ann Neurol 1990; 28(4)512–515
   PubMed Web of Science ®Google Scholar
• Dunne J W, Heye N, Dunne S L. Treatment of chronic limb spasticity with botulinum toxin A. J Neurol Neurosurg Psych 1995; 58(2)232–235
   PubMed Web of Science ®Google Scholar
• Grazko M A, Polo K B, Jabbari B. Botulinum toxin A for spasticity, muscle spasms, and rigidity. Neurology 1995; 45(4)712–717
   PubMed Web of Science ®Google Scholar
• Hesse S, Krajnik J, Luecke D, Jahnke M T, Gregoric M, Mauritz K H. Ankle muscle activity before and after botulinum toxin therapy for lower limb extensor spasticity in chronic hemiparetic patients. Stroke 1996; 27(3)455–460
   PubMed Web of Science ®Google Scholar
• Burbaud P, Wiart L, Dubos J L, Gaujard E, Debelleix X, Joseph P A, Mazaux J M, Bioulac B, Barat M, Lagueny A. A randomised, double blind, placebo controlled trial of botulinum toxin in the treatment of spastic foot in hemiparetic patients. J Neurol Neurosurg Psych 1996; 61(3)265–269
   PubMed Web of Science ®Google Scholar
• Kirazli Y, On A Y, Kismali B, Aksit R. Comparison of phenol block and botulinus toxin type A in the treatment of spastic foot after stroke: A randomized, double-blind trial. Am J Phys Med Rehabil 1998; 77(6)510–515
   PubMed Web of Science ®Google Scholar
• Hyman N, Barnes M, Bhakta B, Cozens A, Bakheit M, Kreczy-Kleedorfer B, Poewe W, Wissel J, Bain P, Glickman S, Sayer A, Richardson A, Dott C. Botulinum toxin (Dysport) treatment of hip adductor spasticity in multiple sclerosis: A prospective, randomised, double blind, placebo controlled, dose ranging study. J Neurol Neurosurg Psych 2000; 68(6)707–712
   PubMed Web of Science ®Google Scholar
• Richardson D, Sheean G, Werring D, Desai M, Edwards S, Greenwood R, Thompson A. Evaluating the role of botulinum toxin in the management of focal hypertonia in adults. J Neurol Neurosurg Psych 2000; 69(4)499–506
   PubMed Web of Science ®Google Scholar
• Pittock S J, Moore A P, Hardiman O, Ehler E, Kovac M, Bojakowski J, Al Khawaja I, Brozman M, Kanovsky P, Skorometz A, Slawek J, Reichel G, Stenner A, Timerbaeva S, Stelmasiak Z, Zifko U A, Bhakta B, Coxon E. A double-blind randomised placebo-controlled evaluation of three doses of botulinum toxin type A (Dysport) in the treatment of spastic equinovarus deformity after stroke. Cerebrovasc Dis 2003; 15(4)289–300
   PubMed Web of Science ®Google Scholar
• Fock J, Galea M P, Stillman B C, Rawicki B, Clark M. Functional outcome following Botulinum toxin A injection to reduce spastic equinus in adults with traumatic brain injury. Brain Inj 2004; 18(1)57–63
   PubMed Web of Science ®Google Scholar
• Johnson C A, Burridge J H, Strike P W, Wood D E, Swain I D. The effect of combined use of botulinum toxin type A and functional electric stimulation in the treatment of spastic drop foot after stroke: A preliminary investigation. Arch Phys Med Rehabil 2004; 85(6)902–909
   PubMed Web of Science ®Google Scholar
• Rousseaux M, Compere S, Launay M J, Kozlowski O. Variability and predictability of functional efficacy of botulinum toxin injection in leg spastic muscles. J Neurol Sci 2005; 15;232(1 – 2)51–57
   PubMed Web of Science ®Google Scholar
• Mancini F, Sandrini G, Moglia A, Nappi G, Pacchetti C. A randomised, double-blind, dose-ranging study to evaluate efficacy and safety of three doses of botulinum toxin type A (Botox) for the treatment of spastic foot. Neurol Sci 2005; 26(1)26–31
   PubMed Web of Science ®Google Scholar
• Cioni M, Esquenazi A, Hirai B. Effects of botulinum toxin-A on gait velocity, step length, and base of support of patients with dynamic equinovarus foot. Am J Phys Med Rehabil 2006; 85(7)600–606
   PubMed Web of Science ®Google Scholar
• Bergfeldt U, Borg K, Kullander K, Julin P. Focal spasticity therapy with botulinum toxin: Effects on function, activities of daily living and pain in 100 adult patients. J Rehabil Med 2006; 38(3)166–171
   PubMed Web of Science ®Google Scholar
• Verplancke D, Snape S, Salisbury C F, Jones P W, Ward A B. A randomized controlled trial of botulinum toxin on lower limb spasticity following acute acquired severe brain injury. Clin Rehabil 2005; 19(2)117–125
   PubMed Web of Science ®Google Scholar
• Molteni F. Botulinum toxin and rehabilitation programs in lower limb spasticity. Eur J Neurol 1995; 2: 61–67
   Web of Science ®Google Scholar
• Reiter F, Danni M, Lagalla G, Ceravolo G, Provinciali L. Low-dose botulinum toxin with ankle taping for the treatment of spastic equinovarus foot after stroke. Arch Phys Med Rehabil 1998; 79: 532–535
   PubMed Web of Science ®Google Scholar
• Hesse S, Werner C, Bardeleben A, Brandl-Hesse B. Management of upper and lower limb sposticity in neuro-rehabilitation. Acta Neurochir Suppl. 2002; 79: 117–122
   PubMedGoogle Scholar
• Houltram J, Noble I, Boyd R N, Corry I, Flett P, Graham H K. Botulinum toxin type A in the management of equinus in children with cerebral palsy: An evidence-based economic evaluation. Eur J Neurol 2001; 8(Suppl. 5)194–202
   PubMed Web of Science ®Google Scholar
• Booth M Y, Yates C C, Edgar T S, Bandy W D. Serial casting vs combined intervention with botulinum toxin A and serial casting in the treatment of spastic equinus in children. Pediatr Phys Ther 2003; 15(4)216–220
   PubMedGoogle Scholar
• Bottos M, Benedetti M G, Salucci P, Gasparroni V, Giannini S. Botulinum toxin with and without casting in ambulant children with spastic diplegia: A clinical and functional assessment. Dev Med Child Neurol 2003; 45(11)758–762
   PubMed Web of Science ®Google Scholar
• Glanzman A M, Kim H, Swaminathan K, Beck T. Efficacy of botulinum toxin A, serial casting, and combined treatment for spastic equinus: A retrospective analysis. Dev Med Child Neurol 2004; 46(12)807–811
   PubMed Web of Science ®Google Scholar
• Ackman J D, Russman B S, Thomas S S, Buckon C E, Sussman M D, Masso P, Sanders J, D'Astous J, Aiona M D, Shriners Hospitals BTX-A Study Group. Comparing botulinum toxin A with casting for treatment of dynamic equinus in children with cerebral palsy. Dev Med Child Neurol 2005; 47(9)620–627
   PubMed Web of Science ®Google Scholar
• Kay R M, Rethlefsen S A, Fern-Buneo A, Wren T A, Skaggs D L. Botulinum toxin as an adjunct to serial casting treatment in children with cerebral palsy. J Bone Joint Surg Am 2004; 86-A(11)2377–2384
   PubMedGoogle Scholar
• Wemove Spasticity Study Group. Spasticity: Etiology, evaluation, management and the role of botulinum toxin, N H Mayer, D M Simpson, 2002
   Google Scholar
• Robertson A, Ashford S, Heward K, Katchburian L, Kent R, O'Brein P, Power T, Wiggins L. The role of physiotherapists in the management of spasticity in adults and paediatric patients: A consensus guideline. ConnectMedical. Mededdlum Group Pty Ltd. 2006
   Google Scholar
• Das-Gupta R, Turner-Stokes L. Traumatic brain injury. Disabil Rehabil 2002; 24(13)654–665
   PubMed Web of Science ®Google Scholar
• Fanucci E, Masala S, Squillaci E, Sodani G, Varrucciu V, Ursone A, Simonetti G. Pyriformis muscle syndrome: CT/MR findings in the percutaneous therapy with botulinic toxin. Radiol Med (Torino) 2003; 105(1 – 2)69–75
   PubMedGoogle Scholar
• Haig A J, Goodmurphy C W, Harris A R, Ruiz A P, Etemad J. The accuracy of needle placement in lower-limb muscles: A blinded study. Arch Phys Med Rehabil 2003; 84: 877–882
   PubMed Web of Science ®Google Scholar
• Childers M K. The importance of electromyographic guidance and electrical stimulation for injection of botulinum toxin. Phys Med Rehabil Clin N Am 2003; 14(4)781–792
   PubMedGoogle Scholar
• Childers M K. Targeting the neuromuscular junction in skeletal muscles. Am J Phys Med Rehabil 2004; 83(10 Suppl.)S38–44
   PubMedGoogle Scholar
• Geenan C, Consky E, Ashby P. Localising muscles for botulinum toxin treatment of focal dystonia. Can J Neurol Sci 1996; 23: 194–197
   PubMed Web of Science ®Google Scholar
• Schroeder A S, Berweck S, Lee S H, Heinen F. Botulinum toxin treatment of children with cerebral palsy – a short review of different injection techniques. Neurotox Res 2006; 9(2 – 3)189–196
   PubMed Web of Science ®Google Scholar
• Childers M K, Kornegay J N, Aoki R, Otaviani L, Bogan D J, Petroski G. Evaluating motor end-plate-targeted injections of botulinum toxin type A in a canine model. Muscle Nerve 1998; 21(5)653–655
   PubMed Web of Science ®Google Scholar
• Gracies J M, Hefter H, Simpson D M, Moore P. Spasticity in adults. Handbook of Botulinum toxin treatment2nd ed, P Moore, M Naumann. Blackwell Science, MassUSA 2003; 219–269
   Google Scholar
• WHO. International classification of function, disability and health. World Health Organization, Geneva 2001, Accessed 8 May 2007 at: www3.who.int/icf/icftemplate.cfm
   Google Scholar
• Gracies J M, Marosszeky J E, Renton R, Sandanam J, Gandevia S C, Burke D. Short-term effects of dynamic lycra splints on upper limb in hemiplegic patients. Arch Phys Med Rehabil 2000; 81(12)1547–1555
   PubMed Web of Science ®Google Scholar
• Harvey L A, Herbert R D. Muscle stretching for treatment and prevention of contracture in people with spinal cord injury. Spinal Cord 2002; 40(1)1–9
   PubMed Web of Science ®Google Scholar
• Harvey L A, Batty J, Crosbie J, Poulter S, Herbert R D. A randomized trial assessing the effects of 4 weeks of daily stretching on ankle mobility in patients with spinal cord injuries. Arch Phys Med Rehabil 2000; 81: 1340–1347
   PubMed Web of Science ®Google Scholar
• Harvey L A, Byak A J, Ostrovskaya M, Glinsky J, Katte L, Herbert R D. Randomised trial of the effects of four weeks of daily stretch on extensibility of hamstring muscles in people with spinal cord injuries. Aust J Physiother 2003; 49: 176–181
   PubMed Web of Science ®Google Scholar
• Ben M, Harvey L, Denis S, Glinsky J, Goehl G, Chee S, Herbert R D. Does 12 weeks of regular standing prevent loss of ankle mobility and bone mineral density in people with recent spinal cord injuries?. Aust J Physiother 2005; 51(4)251–256
   PubMed Web of Science ®Google Scholar
• Mortenson P A, Eng J J. The use of casts in the management of joint mobility and hypertonia following brain injury in adults: A systematic review. Phys Ther 2003; 83(7)648–658
   PubMed Web of Science ®Google Scholar
• Singer B J, Dunne J W, Singer K P, Jegasothy G M, Allison G T. Non-surgical management of ankle contracture following acquired brain injury. Disabil Rehabil 2004; 26(6)335–345
   PubMed Web of Science ®Google Scholar
• Singer B J, Jegasothy G M, Singer K P, Allison G T. Evaluation of serial casting to correct equinovarus deformity of the ankle after acquired brain injury in adults. Arch Phys Med Rehabil 2003; 84(4)483–491
   PubMed Web of Science ®Google Scholar
• Jacobs P L, Nash M S. Modes, benefits, and risks of voluntary and electrically induced exercise in persons with spinal cord injury. J Spinal Cord Med 2001; 24(1)10–18
   PubMedGoogle Scholar
• Morris S L. Outcomes of progressive resistance strength training following stroke: A systematic review. Clin Rehabil 2004; 18(1)27–39
   PubMed Web of Science ®Google Scholar
• White L J, McCoy S C, Castellano V, Gutierrez G, Stevens J E, Walter G A. Vandenborne. Resistance training improves strength and functional capacity in persons with multiple sclerosis. Mult Scler 2004; 10(6)668–674
   PubMed Web of Science ®Google Scholar
• Patten C, Lexell J, Brown H E. Weakness and strength training in persons with post-stroke hemiplegia: Rationale, method, and efficacy. J Rehabil Res Dev 2004; 41(3A)293–312
   PubMed Web of Science ®Google Scholar
• Gutierrez G M, Chow J W, Tillman M D, McCoy S C, Castellano V, White L J. Resistance training improves gait kinematics in persons with multiple sclerosis. Arch Phys Med Rehabil 2005; 86(9)1824–1829
   PubMed Web of Science ®Google Scholar
• Ada L, Dorsch S, Canning C. Strengthening interventions increase strength and improve activity after stroke: A systematic review. Aust J Physio 2006; 52: 241–248
   PubMed Web of Science ®Google Scholar
• Taylor N F, Dodd K J, Prasad D, Denisenko S. Progressive resistive exercise for people with multiple sclerosis. Disabil Rehabil 2006; 28(18)1119–1126
   PubMed Web of Science ®Google Scholar
• Ryan A S, Dobrovolny C L, Smith G V, Silver K H, Macko R F. Hemiparetic muscle atrophy and increased intramuscular fat in stroke patients. Arch Phys Med Rehabil 2002; 83: 1703–1707
   PubMed Web of Science ®Google Scholar
• Ada L, Canning C G, Low S L. Stroke patients have selective muscle weakness in shortened range. Brain 2003; 126(Pt 3)724–731
   PubMed Web of Science ®Google Scholar
• Koo T K, Mak A F, Hung L K, Dewald J P. Joint position dependence of weakness during maximum isometric voluntary contraction in subjects with hemiparesis. Arch Phys Med Rehabil 2003; 84: 1380–1386
   PubMed Web of Science ®Google Scholar
• Canning C G, Shepherd R B, Carr J H, Alison J A, Wade L, White A. A randomized controlled trial of the effects of intensive sit-to-stand training after recent traumatic brain injury on sit-to-stand performance. Clin Rehabil 2003; 17(4)355–362
   PubMed Web of Science ®Google Scholar
• Moseley A M, Stark A, Cameron I D, Pollock A. Treadmill training and body weight support for walking after stroke. Cochrane Database Syst Rev 2005; 19(4), CD00284
   Google Scholar
• Macko R F, Ivey F M, Forrester L W. Task-oriented aerobic exercise in chronic hemiparetic stroke: Training protocols and treatment effects. Top Stroke Rehabil 2005; 12(1)45–57
   PubMedGoogle Scholar
• Macko R F, Ivey F M, Forrester L W, Hanley D, Sorkin J D, Katzel L I, Silver K H, Goldberg A P. Treadmill exercise rehabilitation improves ambulatory function and cardiovascular fitness in patients with chronic stroke: A randomized, controlled trial. Stroke 2005; 36(10)2206–2211
   PubMed Web of Science ®Google Scholar
• Peurala S H, Tarkka I M, Pitkanen K, Sivenius J. The effectiveness of body weight-supported gait training and floor walking in patients with chronic stroke. Arch Phys Med Rehabil Aug, 2005; 86(8)1557–1564
   PubMed Web of Science ®Google Scholar
• Sheean G L. Botulinum treatment of spasticity: Why is it so difficult to show a functional benefit?. Curr Opin Neurol 2001; 14(6)771–776
   PubMed Web of Science ®Google Scholar
• Sheean G. Botulinum toxin treatment of adult spasticity: A benefit-risk assessment. Drug Saf 2006; 29(1)31–48
   PubMed Web of Science ®Google Scholar